NR2-reactive antibody decreases cell viability through augmentation of Ca 2+ influx in systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3952-3959

  Gono, Takahisa ^a   Takarada, Takeshi ^b   Fukumori, Ryo ^b   Kawaguchi, Yasushi ^a   Kaneko, Hirotaka ^a   Hanaoka, Masanori ^a   Katsumata, Yasuhiro ^a   Yoneda, Yukio ^b   Yamanaka, Hisashi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DOUBLE STRANDED DNA ANTIBODY; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2 REACTIVE ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG; ZINC;

ARTICLE; CALCIUM TRANSPORT; CELL VIABILITY; CLINICAL ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES; ANTIBODIES, ANTINUCLEAR; CALCIUM; CASE-CONTROL STUDIES; CELL SURVIVAL; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; RECEPTORS, N-METHYL-D-ASPARTATE; ZINC;

EID: 82455198797     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30616     Document Type: Article

References (36)

1. Lynch D, Anegawa N, Verdoorn T, Pritchett D,. N-methyl-D-aspartate receptors: different subunit requirements for binding of glutamate antagonists, glycine antagonists, and channel-blocking agents. Mol Pharmacol 1994; 45: 540-5. (Pubitemid 24094945)
2. Kalia L, Kalia S, Salter M,. NMDA receptors in clinical neurology: excitatory times ahead. Lancet Neurol 2008; 7: 742-55. (Pubitemid 351957932)
3. Waxman E, Lynch D,. N-methyl-D-aspartate receptor subtypes: multiple roles in excitotoxicity and neurological disease. Neuroscientist 2005; 11: 37-49. (Pubitemid 40223089)
4. Coyle J,. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol 2006; 26: 365-84.
5. Lau C, Zukin R,. NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders. Nat Rev Neurosci 2007; 8: 413-26. (Pubitemid 46789232)
6. Dalmau J, Tuzun E, Wu H, Masjuan J, Rossi J, Voloschin A, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36. (Pubitemid 46214241)
7. Dalmau J, Gleichman A, Hughes E, Rossi J, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008; 7: 1091-8.
8. Iizuka T, Sakai F,. Anti-nMDA receptor encephalitis-clinical manifestations and pathophysiology. Brain Nerve 2008; 60: 1047-60. In Japanese.
9. DeGiorgio LA, Konstantinov K, Lee S, Hardin J, Volpe B, Diamond B,. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189-93. (Pubitemid 33063773)
10. Gono T, Kawaguchi Y, Kaneko H, Nishimura K, Hanaoka M, Kataoka S, et al. Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. Rheumatology (Oxford) 2011; 50: 1578-85.
11. Husebye E, Sthoeger Z, Dayan M, Zinger H, Elbirt D, Levite M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis 2005; 64: 1210-3. (Pubitemid 41113359)
12. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellgren S,. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol 2005; 12: 392-8. (Pubitemid 40524182)
13. Hanly J, Robichaud J, Fisk J,. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. J Rheumatol 2006; 33: 1553-8. (Pubitemid 44168826)
14. Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, et al. Anti-N-methyl- D -aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2505-14. (Pubitemid 44205011)
15. Harrison MJ, Ravdin LD, Lockshin MD,. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2515-22. (Pubitemid 44205012)
16. Arinuma Y, Yanagida T, Hirohata S,. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1130-5. (Pubitemid 351564016)
17. Kowal C, DeGiorgio L, Lee J, Edgar M, Huerta P, Volpe B, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A 2006; 103: 19854-9. (Pubitemid 46037520)
18. Faust TW, Chang EH, Kowal C, Berlin R, Gazaryan IG, Bertini E, et al. Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A 2010; 107: 18569-74.
19. Yuan H, Hansen K, Vance K, Ogden K, Traynelis S,. Control of NMDA receptor function by the NR2 subunit amino-terminal domain. J Neurosci 2009; 29: 12045-58.
20. Karakas E, Simorowski N, Furukawa H,. Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit. EMBO J 2009; 28: 3910-20.
21. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
22. Taniura H, Iijima S, Kambe Y, Georgiev D, Yoneda Y,. Tex261 modulates the excitotoxic cell death induced by N-methyl-D-aspartate (NMDA) receptor activation. Biochem Biophys Res Commun 2007; 362: 1096-100. (Pubitemid 47390688)
23. 2+ influx through acquired and native N-methyl-D-aspartate-receptor channels. J Pharmacol Sci 2010; 112: 273-81.
24. 2+ mobilization mediated by acquired N-methyl-D-aspartate receptor channels into mitochondria. Neurochem Int 2010; 57: 730-7.
25. Mosmann T,. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63. (Pubitemid 14203433)
26. 2+ influx through N-methyl-D-aspartate receptor channels in immature cultured rat cortical neurons. J Neurochem 2002; 83: 1-11.
27. Liu Y, Wong TP, Aarts M, Rooyakkers A, Liu L, Lai TW, et al. NMDA receptor subunits have differential roles in mediating excitotoxic neuronal death both in vitro and in vivo. J Neurosci 2007; 27: 2846-57. (Pubitemid 46438991)
28. Choi D, Rothman S,. The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death. Annu Rev Neurosci 1990; 13: 171-82. (Pubitemid 20100647)
29. Mattson M, LaFerla F, Chan S, Leissring M, Shepel P, Geiger J,. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci 2000; 23: 222-9. (Pubitemid 30236182)
30. Akbarian S, Sucher N, Bradley D, Tafazzoli A, Trinh D, Hetrick W, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J Neurosci 1996; 16: 19-30. (Pubitemid 26010694)
31. 2+ signals and neuronal death in brain ischemia. Stroke 2007; 38 Suppl: 674-6. (Pubitemid 46184239)
32. Orrenius S, Zhivotovsky B, Nicotera P,. Regulation of cell death: the calcium-apoptosis link. Nat Rev Mol Cell Biol 2003; 4: 552-65. (Pubitemid 36773407)
33. Gielen M, Siegler Retchless B, Mony L, Johnson J, Paoletti P,. Mechanism of differential control of NMDA receptor activity by NR2 subunits. Nature 2009; 459: 703-7.
34. Dingledine R, Borges K, Bowie D, Traynelis S,. The glutamate receptor ion channels. Pharmacol Rev 1999; 51: 7-61. (Pubitemid 29113865)
35. Paoletti P, Neyton J,. NMDA receptor subunits: function and pharmacology. Curr Opin Pharmacol 2007; 7: 39-47. (Pubitemid 46238036)
36. Abbott N, Mendonça L, Dolman D,. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003; 12: 908-15. (Pubitemid 38082086)